Regenerative Medicine Market Size Worth $5.59 Billion By 2025 | Key Industry participants Asterias Bio & Integra LifeSciences Corpotation

San Francisco, 21 Dec 2018 – “Regenerative Medicine Market Analysis By Product (Therapeutics {Primary Cell-based, Stem Cell-based, Immunotherapies, & Gene Therapies}, Tools, Banks, & Services), By Therapeutic Category, And Segment Forecasts, 2018 - 2025” According to a report by Grand View Research, Inc.; the global regenerative medicine market is projected to value USD 5.59 billion by 2025. High prevalence of orthopedic, neurodegenerative, and other aging-related disorders is anticipated to propel the market. Rise in geriatric population can further fuel market expansion over the forecast period (2014 to 2025).

Continual technological advancements in tissue engineering, gene therapy, and nanotechnology can stimulate expansion of the market for regenerative medicine. Increasing R&D investments by private and government organizations can also impel growth. Rapid developments in biotechnology provide in-depth knowledge regarding metabolism mechanism, cell division, and cell differentiation. Development of new streams of biotechnology like nanotechnology and gene therapy can augment use of cell-based technology in therapeutic procedures. This, in turn, can stimulate market expansion in the forthcoming years.

Access Full Insights On Regenerative Medicine Market: www.grandviewresearch.com/industry-analysis/regenerative-medicine-market

The worldwide regenerative medicine market is segregated on the basis of product, therapeutic category, and region. Based on product, the market is categorized into therapeutics and devices, stem cell and progenitor cell-based therapeutics, banks, tools, and services. In 2016, therapeutics held the largest market share owing to high implementation. Introduction of various gene and cell-based therapies is expected to contribute to the growth.

In addition, emergence of regulatory policies to promote research activities related to cell therapy can positively influence market expansion. Such supportive policies can encourage researchers to further explore induced Pluripotent Stem Cells (iPSC). Moreover, development of gene therapy techniques to restore and rectify effects of gene mutations in cells is underway. Mutations inducing degenerative characteristics along with to the conditions caused by Single Nucleotide Polymorphism (SNP) are targeted by these gene therapies.

On the contrary, stringent regulations regarding the use of Human Embryonic Stem Cells (HESC) may restrict growth of the market for regenerative medicine. However, regulatory changes introduced by countries like United Kingdom, United States, China, and Japan attributed to identification of clinical applications are expected to augment market expansion in the forthcoming years.

Based on therapeutic category, the market can be classified into oncology, musculoskeletal, cardiovascular, ophthalmology, dermatology, immunology and inflammation, and others. Dermatology is projected to hold the largest market share during the forecast period. Availability of easy drafting methods to treat dermatology diseases and wounds can propel growth of segment. Skin is an organ that offers great cell replication characteristics. Different types of stem cells are found in different layers of skin. Availability of wide range of products like patches and grafts to treat minor injuries and chronic burns and wounds respectively, can stimulate segment growth during the forecast period.

Oncology is estimated to witness the most significant growth over the forecast period. Rising investment in research activities and availability of pipeline products can propel this expansion. High prevalence of cancer and increasing expenses for treatment can positively influence growth. However, challenges associated with clinical experiments are expected to hinder the expansion in near future.

Regional segmentation includes North America, Asia Pacific, Europe, Latin America, and Middle East and Africa. North America is anticipated to hold the largest market share attributed to presence of leading market players. In addition, continual technological advancements and investments in oncology and stem cells research can further augment regional growth.

Asia Pacific is projected to witness the fastest CAGR over the forecast period attributed to rising healthcare investments by growing economies. Technological advancements in stem cell research can further propel regional market for regenerative medicine. In addition, availability of flexible regulations regarding adoption of cell-based regenerative therapies can boost market expansion. Moreover, growing investments by private and government companies to boost development of novel technologies can stimulate market growth over the forecast period.

Some of the leading companies operating in the regenerative medicine market are Integra LifeSciences Corporation, Corline Biomedical AB, Bayer BV, F. Hoffmann-La Roche Ltd, and Vericel Corporation. Most companies are likely to invest in development of regenerative therapies to capture untapped opportunities in the field. They focus on developing novel therapies that can meet clinical requirements. 

Access More Reports Of The Same Category: www.grandviewresearch.com/industry/biotechnology

Grand View Research has segmented the global regenerative medicine market on the basis of product, therapeutic category, and region: 

Regenerative Medicine Product Outlook (Revenue, USD Million, 2014 - 2025)

• Therapeutics & Devices
  • Primary Cell-bases therapeutics 
    • Dermatology
    • Musculoskeletal
    • Surgical
    • Dental
    • Others
  • Stem Cell & Progenitor Cell-based therapeutics
    • Autologous
    • Allogeneic
    • Others
  • Tools
  • Banks
  • Services

Regenerative Medicine Therapeutic Category Outlook (Revenue, USD Million, 2014 - 2025)

• Dermatology
• Musculoskeletal
• Immunology & Inflammation
• Oncology
• Cardiovascular
• Ophthalmology
• Others

Regenerative Medicine Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK
• Asia Pacific
  • China
  • Japan
• Latin America
  • Brazil
• Middle East & Africa
  • South Africa

Browse Press Release of this Report: www.grandviewresearch.com/press-release/global-regenerative-medicine-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Plating on Plastics Market Is Poised To Reach $777.27 Million By 2025

San Francisco, 21 Dec 2018  - “Plating on Plastics (POP) Market Analysis, By Plating (Chrome, Nickel), By Plastic (ABS, ABS/PC, PEI, PBT, LCP, PEEK, PP, Nylon/Polyamide), By Application (Automotive, Construction, Utilities, Electronics) And Segment Forecasts, 2018 - 2025” According to a report published by Grand View Research, Inc.; the global Plating On Plastics (POP) market is expected to reach at USD 777.27 million by 2025. Plating on plastics involves the process of electroplating the plastic with metals like chrome, nickel, silver, copper, and so on. This offers functional benefits, such as toughness, excellent surface quality, and flexibility, to the final product. Increasing usage in electronics and automotive applications is projected to drive the market over the forecast period (from 2018 to 2025). Growing need for lightweight materials in automobile production for improved efficiency and reduced CO2 emissions will boost the POP demand during the forecast period.

In addition, technological advancements, such as the advent of double layer nickel systems that enhances the corrosion resistance capability, will drive the market further. On the other hand, strict regulatory frameworks may hamper the market growth. For instance, the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) has banned the use of hexavalent chromium in POP. The global plating on plastics market can be segmented on the basis of plating type, plastic type, application, and region. Based on plating type, the market can be categorized into chrome, nickel, and others. The nickel plating is the most preferred method in automotive manufacturing for decorative purposes.

Access Full Research Report On POP Market: www.grandviewresearch.com/industry-analysis/plating-on-plastics-pop-market

It is used to improve the appearance of the vehicles. The nickel also helps improve corrosion and wear resistance of plastic substrate. Copper is another preferred metal for coating large plastic components due to its higher conductivity. As per plastic type, the market can be divided into Acrylonitrile Butadiene Styrene (ABS), ABS/PC, Polyetherimide (PEI), Polybutylene Terephthalate (PBT), Liquid-Crystal Polymer (LCP), Polyether Ether Ketone (PEEK), Polypropylene (PP), and Nylon/Polyamide. The ABS segment is mainly driven due to its low costs, low coefficient of thermal expansion, high metallic adhesion, and ease of molding. Acrylonitrile butadiene styrene is the most widely utilized in the global market.

However, the ABS/PC segment is likely to expand at the fastest CAGR of 8.6% from 2018 to 2025. This blend consists of 40 to 60% of ABS and the remaining portion contains Polycarbonate (PC). It provides better strength and ductility and can be used in extreme temperatures. Based on application, the market can be split into automotive, building and construction, utilities, electronics, and others. Nickel and chromium coatings are extensively used in the automotive segment due to its benefits including weight reduction, aesthetic designs, and lower cost. The electronics segment is projected to expand at the fastest CAGR of 8.1% from 2018 to 2025.

Nickel and nickel/chromium masking are used to enhance the aesthetic appearance of plastic trims on mobile phones, computers, and switches in electronic goods. The utility segment is also expected to have a significant growth in the coming years. Advantages, such as protection from rust and water, have increased the product application scope in this segment. Geographically, the market can be divided into North America, Europe, Asia Pacific, Central and South America, and Middle East and Africa. Europe is the leading market in terms of revenue, followed by North America. Strong base of automotive industry in Germany and U.K. are supporting the market growth in Europe.

Demand for lightweight aerodynamic is on the rise in Europe due to strict of environmental regulations. Asia Pacific is expected to register the fastest CAGR of 8.2% over the forecast period. Growing electronics and automotive manufacturing industries in countries, such as Japan, India, and China, are anticipated to drive the regional market. In addition, rapid development of industrial infrastructure is also expected to provide lucrative growth opportunities in the region. Key companies in the global plating on plastics (POP) market include Sharrets Plating Inc.; Cybershield Inc.; MPC Plating Inc.; Galva Decoparts Pvt. Ltd.; and Grauer & Weil (India) Limited.

Access More Reports Of The Same Category: www.grandviewresearch.com/industry/paints-coatings-and-printing-inks

Grand View Research has segmented the global POP market on the basis of plating type, plastic type, application and region

Plating Type Outlook (Revenue, USD Million, 2014 - 2025)

• Chrome
• Nickel
• Others

Plastic Type Outlook (Revenue, USD Million, 2014 - 2025)

• ABS
• ABS/PC
• PEI
• PBT
• LCP
• PEEK
• PP
• Nylon/Polyamide

Application Outlook (Revenue, USD Million, 2014 - 2025)

• Automotive
• Building & Construction
• Utilities
• Electronics
• Others

Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
  • US.
• Europe
  • UK
  • Germany
• Asia Pacific
  • China
  • India
• Central & South America
  • Brazil
• Middle East & Africa
  • Saudi Arabia 

Browse Press Release of this Report: www.grandviewresearch.com/press-release/global-plating-on-plastics-pop-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Aerospace Coatings Market Worth $2.48 Billion By 2025 | Top Companies Are AkzoNobel N.V & PPG Industries, Inc.

San Francisco, 21 Dec 2018 - “Aerospace Coating Market Size, Share & Trends Analysis Report By Resin (Epoxy, PU), By Product, By Application (Exterior, Interior), By End User, By Industry Category, And Segment Forecasts, 2018 – 2025” The global aerospace coatings market size is projected to reach USD 2.48 billion by 2025, according to a new report by Grand View Research, Inc., progressing at a CAGR of 6.0% during the forecast period. Increasing air passenger traffic is one of the key factors driving the aviation industry, which translates into greater demand for aerospace coatings.

Aerospace coatings offer aesthetic appeal and resistance towards corrosion, chemical, electrical and erosion. They are designed and formulated to obtain extended aircraft life. The growth of the aviation industry due to increasing per capita income and rising air cargo transports is expected to fuel the demand for the product. The demand for polyurethane resin is anticipated to be high throughout the forecast period as they hold very low VOC content and are chromate-free in nature.

North America was the largest market for aerospace coatings in 2017. It is poised to retain its position through 2025. The region is likely to register a healthy growth rate during the forecast period, owing to substantial demand from the U.S. Countries in Europe have been investing in manufacturing of commercial aircrafts, aiming to reduce imports of aircraft from the U.S. This, in turn, has resulted in considerable demand for these coatings in countries such as Germany, France, U.K., and Italy.

Surging demand for air travel from countries such as China and Japan is estimated to drive the market in Asia Pacific over the forecast years. Presence of various long airline routes in Asia Pacific is boosting the demand for aerospace coatings. Several government initiatives in countries such as encouraging private investments in the aerospace industry to allow domestic aerospace companies to compete globally are expected to foster the demand for aerospace coatings in Asia Pacific

To request a sample copy or view summary of this report, click the link below: www.grandviewresearch.com/industry-analysis/aerospace-coatings-market 

Further key findings from the report suggest:

• In terms of volume, the polyurethane resin segment is expected to witness steady growth of 5.4% over the forecast period, owing to increasing demand from commercial aviation OEMs
• The liquid product segment dominated the global market in 2017, with a revenue share of 74.1%
• In terms of volume, the military end-user segment is projected to witness the highest CAGR of 5.5% from 2018 to 2025
• There will be a high demand for aerospace coating from the MRO industry in Asia Pacific, owing to surging demand in countries such as Singapore, China, and South Korea
• The exterior application segment dominated the market, with a revenue share of over 70.0% in 2017, owing to its increased use in the commercial and military end-user segment
• The U.S. aerospace coatings market is anticipated to exceed 9.72 kilotons by 2025, owing to increasing military spending and higher demand for passenger travel
• The market has intense competition among key players owing to the fact that the products offered by manufacturers have low differentiation
• Some of the key companies present in the market are AkzoNobel N.V; PPG Industries, Inc.; Sherwin-Williams; Hentzen Coatings, Inc.; and Mankiewicz Gebr. & Co; Axalta Coating Systems Ltd; Saint-Gobain S.A; Henkel Corporation; IHI Ionbond AG; Zircotec Ltd; LORD Corporation; AHC Oberflächentechnik; BryCoat Inc.; and NV Specialty Coatings.

Access More Repors Of The Same Category: 
www.grandviewresearch.com/industry/bulk-chemicals

Grand View Research has segmented the global aerospace coatings market on the basis of resin, product, end user, industry category, application, and region.

Resin Outlook (Volume, Tons; Revenue, USD Million, 2014 - 2025)

• Epoxy
• Polyurethane
• Others

Product Outlook (Volume, Tons; Revenue, USD Million, 2014 - 2025)

• Liquid
• Powder

End User Outlook (Volume, Tons; Revenue, USD Million, 2014 - 2025)

• Commercial
• Military
• Others

Industry Category Outlook (Volume, Tons; Revenue, USD Million, 2014 - 2025)

• OEM
• MRO

Application Outlook (Volume, Tons; Revenue, USD Million, 2014 - 2025)

• Exterior
• Interior

Regional Outlook (Volume, Tons; Revenue, USD Million, 2014 - 2025)

• North America
  • US
• Europe
  • Germany
  • UK.
  • France
  • Italy
• Asia Pacific
  • China
  • Japan
• Central & South America
  • Brazil
• Middle East & Africa 

Browse Press Release of this Report:  www.grandviewresearch.com/press-release/global-aerospace-coatings-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Primary Cell Culture Market Worth $5.4 Billion By 2025 l Top Companies Are Merck & Thermo Fisher Scientific

San Francisco, 20 Dec 2018  - “Primary Cell Culture Market Analysis Report By Product, By Application (Stem Cell Therapy, Vaccine Production), By Separation and Culture Method, By Region, And Segment Forecasts, 2018 – 2025” The global primary cell culture market size is expected to reach USD 5.4 billion by 2025 and is expected to register a CAGR 10.6% during the forecast period,according to a new report by Grand View Research, Inc. Growth in production of vaccines, monoclonal antibodies, and regenerative medicines, patent expiration of blockbuster biologics, and rising demand for stem cell therapy and tissue engineering are factors promoting the growth of this market. These trends are attracting big players in healthcare and medical research toward this field.

Primary cell culture is increasingly being used in fields such as drug screening, organogenesis, disease diagnosis, biological product manufacturing, cancer research, and stem cell research. Due to their increased use in various healthcare domains, private medical organizations, pharmaceutical and biotech companies, education, research and government organizations have increased their investments and funding in this market.

Primary cells show high physiological resemblance to the tissues and organs they are extracted from. This provides immense help to researchers and scientists in understanding various complexities related to drug pathways, studying diseases and drug development, and their effect on biological site of action in-vivo. Due to these qualities, their use has increased in biopharmaceuticals, transplants, and chronic disease therapies. Their sprouting customized use for different research purposes is also a key trend in the industry.

However, there are many ethical concerns over the usage of human embryonic cells, which poses as a major restraint in the growth of this market. Usage of transgenic plants and animals and stem cells, as well as stringent rules and regulations associated with it, will also negatively affect market growth in the years to come.

Currently, North America holds the largest share in the market, with Asia Pacific expected to witness the fastest growth during the forecast period. This can be attributed to rising per capita incomes, growing healthcare affordability, and improving economic status of countries such as India and China.

Commercial players in this market are mostly established companies; however, several new players have been making their presence known in recent years. Some of the key players are Merck KGaA; Lonza; Promocell GmbH; GE Healthcare; and Corning, Inc.

To request a sample copy or view summary of this report, click the link below:www.grandviewresearch.com/industry-analysis/primary-cell-culture-market

Further key findings from the report suggest:

• Growing need for stem cells transplants and increasing number of clinical research studies and medical therapies for chronic diseases are expected to drive the market
• Increasing prevalence of chronic illnesses all over the world and ongoing researches in several therapeutic areas has resulted in rapid advancements in stem cell therapy, cancer treatment, gene therapy, and regenerative medicine
• While media held the dominant share by way of product, the reagents and supplements segment is expected to register a CAGR of 10.8% during the forecast period
• On the basis of separation and culture technique, enzymatic disaggregation held the dominant share in 2017. This is due to high productivity yield and less damage associated with this technique. Enzymes widely used for carrying out degradation process include trypsin, collagenase, and papain
• North America holds the largest revenue share in the market. Registering a CAGR of 12.2% during the forecast period, Asia Pacific is poised to emerge as the fastest growing region in the coming years
• Lonza, Merck, Thermo Fisher, and GE Healthineers are some of the leading players in this market. The number of new players venturing in this space is increasing each year.

Access More Reports Of The Same Category: www.grandviewresearch.com/industry/biotechnology

Grand View Research has segmented the global primary cell culture market based on product, application, separation and culture technique, and region:

Primary Cell Culture Product Outlook (Revenue, USD Million, 2014 - 2025)

• Primary Cell
  • Fat
  • Blood
  • Nerve
  • Bone
  • Endothelial
  • Skin
  • Muscle
  • Stem
  • Others
• Reagents and Supplements
  • Attachment Solutions
  • Buffers and Salts
  • Freezing Media
  • Sera
  • Growth Factors and Cytokines
  • Others
• Media
  • Fat Media
  • Blood Media
  • Nerve Media
  • Bone Media
  • Endothelial Media
  • Skin Media
  • Muscle Media
  • Stem Media
  • Others

Primary Cell Culture Application Outlook (Revenue, USD Million, 2014 - 2025)

• Tissue Culture & Tissue Engineering
• Vaccine Production
• Gene Therapy and Regenerative Medicine
• Toxicity Testing and Drug Screening
• Cancer Research
• Model System
• Virology
• Prenatal Diagnosis
• Stem Cell Therapy
• Others

Primary Cell Culture Separation and Culture Techniques Outlook (Revenue, USD Million, 2014 - 2025)

• Explant Method
• Enzymatic Disaggregation
  • Trypsin
  • Collagenase
  • Protease
  • Pronase
  • Dispase
  • Hyaluronidase
  • Neuraminidase
  • Elastase
  • DNase
  • Papain
  • Accutase
  • Others
• Mechanical Separation
• Others

Primary Cell Culture Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
• Asia Pacific
  • China
  • Japan
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa
  • South Africa

Browse Press Release of this Report: www.grandviewresearch.com/press-release/global-primary-cell-culture-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Stem Cell Market Is Predicted To Reach $15.63 Billion By 2025: Grand View Research, Inc.

San Francisco, 20 Dec 2018 - “Stem Cells Market Analysis By Product (Adult Stem Cells, hESC, Induced Pluripotent Stem Cells), By Application (Regenerative Medicine, Drug Discovery), By Technology, By Therapy, And Segment Forecasts, 2018 – 2025" - According to a report published by Grand View Research, Inc.; the global stem cells market is projected to reach around USD 15.63 billion by 2025. Increasing scope in clinical applications can drive the market growth during the forecast period (2014 to 2025). Rising research activities focused on boosting the application scope of stem cells is anticipated to positively influence market expansion in near future. These research activities have opened new avenues in terms of implementation of stem cells in regenerative medicine and disease management.

Technological innovations such as continuous supply of induced Pluripotent Stem Cells (iPSCs) and efforts for regeneration of diseased or dying cells are also expected to accelerate growth of the market. Additionally, funding for R&D from government as well as private organizations is expected to fuel the growth over the forecast period. Cellular therapy is recognized as the next big advancement in healthcare sector. Efforts from organizations to build their cellular therapy portfolio is expected to drive the market.

Access In-depth Insights On Stem Cells Market: www.grandviewresearch.com/industry-analysis/stem-cells-market

The worldwide stem cells market can be segmented on the basis of product, application, technology, therapy, and region. Based on product, the market can be categorized into induced pluripotent, adult, human embryonic, and very small embryonic like stem cells. Adult stem cell segment is further divided into neuronal, mesenchymal, hematopoietic, and umbilical cord, among others.

The adult stem cells segment is anticipated to continue leading the market during the forecast period. Factors such as long term renewal property and lesser rejection rate are driving the growth. There are no ethical concerns associated with the use of these cells. This factor is anticipated to bode well for the demand in near future. Also, research activities related to organoid generation and drug screening are considered as crucial factors for the segment growth.

As per application, the market for stem cells can be categorized into regenerative medicine and drug discovery and development. The regenerative medicine segment is further classified into neurology, orthopedics, oncology, hematology, cardiovascular and myocardial infraction, injuries, diabetes, liver disorders, and incontinence, among others.

Regenerative medicine is anticipated to hold a significant market share over the forecast period due to existence of numerous pipeline projects. These medicines can cure traumatic injuries and degenerative diseases. Neurology segment is anticipated to hold major market share in terms of revenue owing to availability of the Food and Drug Administration (FDA) approved products. Oncology segment is expected to grow on account of presence of strong pipeline medicines for cancer therapies.

Based on technology, the stem cells market is classified into cell acquisition, cryopreservation, cell production, and expansion and sub-culture. Cell acquisition is further categorized into bone marrow harvest, umbilical blood cord, and apheresis. The segment is anticipated to occupy the largest market share throughout the forecast period owing to their growing importance in cell harvesting. Development of new cells using bone marrow is quicker therefore, it is the most preferred technology. The cell production segment held substantial market share in the past due to constant technological advancements to meet the ever-increasing demand from clinical applications.

As per therapy, the market is split into autologous and allogeneic stem cell therapy. In terms of revenue, the autologous stem cell therapy segment led the market in 2016 due to high acceptance of these products. Moreover, high compatibility of these cells is anticipated to further propel the uptake over the forecast period.

Geographically, the market can be divided into Europe, North America, Asia Pacific, Latin America, and Middle East and Africa. North America is anticipated to account for a large market share over the forecast period. Increasing R&D activities coupled with funding for advanced cellular therapy is projected to bode well for the regional market expansion. Asia Pacific is projected to showcase momentous growth over the forecast period. Ongoing R&D projects in countries such as Singapore, Australia, and Japan are projected impel the regional expansion.

Enhanced commercialization opportunities are likely to further boost the market growth. Also, updated regulatory framework related to regenerative medicine in Japan is projected to create business opportunities in near future. North America holds the large share of the market. This is credited to extensive R&D efforts and huge funding for advance cellular research in the U.S.

Some of the leading companies operating in the stem cells market include Cellular Engineering Technologies Inc.; BrainStorm Cell Therapeutics; Bioheart Inc.; Advanced Cell Technology Inc.; and PromoCell GmbH.

Grand View Research has segmented the global stem cells market on the basis of product, application, technology, therapy, and region:

Stem Cell Product Outlook (Revenue, USD Billion, 2014 - 2025)

• Adult Stem Cells
  • Neuronal Stem Cells
  • Hematopoietic Stem Cells
  • Mesenchymal Stem Cells
  • Umbilical Cord Stem Cells
  • Others
• Human Embryonic Stem Cells
• Induced Pluripotent Stem Cells
• Very Small Embryonic Like Stem Cells

Stem Cell Application Outlook (Revenue, USD Billion, 2014 - 2025)

• Regenerative Medicine
  • Neurology
  • Orthopedics
  • Oncology
  • Hematology
  • Cardiovascular and Myocardial Infraction
  • Injuries
  • Diabetes
  • Liver Disorder
  • Incontinence
  • Others
• Drug Discovery and Development

Stem Cell Technology Outlook (Revenue, USD Billion, 2014 - 2025)

• Cell Acquisition
  • Bone Marrow Harvest
  • Umbilical Blood Cord
  • Apheresis
• Cell Production
  • Therapeutic Cloning
  • In-vitro Fertilization
  • Cell Culture
  • Isolation
• Cryopreservation
• Expansion and Sub-Culture

Stem Cell Therapy Outlook (Revenue, USD Billion, 2014 - 2025)

• Autologous Stem Cell Therapy
• Allogeneic Stem Cell Therapy

Stem Cell Regional Outlook (Revenue, USD Billion, 2014 - 2025)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK
• Asia Pacific
  • China
  • Japan
• Latin America
  • Brazil
• Middle East & Africa
  • South Africa

Browse Press Release of this Report: www.grandviewresearch.com/press-release/global-stem-cells-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Structural Steel Market Size Worth $140.4 Billion By 2025 | Top Companies Are Baogang Group, Bohai Group Co.

San Francisco, 20 Dec 2018 -  “Structural Steel Market Analysis By Application (Non Residential (Industrial, Commercial, Offices, Institutional), Residential), By Region, Competitive Landscape, And Segment Forecasts, 2018 – 2025” - The global structural steel market is expected to reach USD 140.4 billion by 2025, according to a new report by Grand View Research, Inc. recovery of construction industry in developed markets of the U.S., Germany and UK is expected to foster industry growth.

Increasing awareness among end-users owing to advantages such as design flexibility, energy efficiency and faster completion of prefabricated/engineered building (PEBs) projects using channels and beams is expected to drive demand. Upsurge in infrastructure development projects in China and India, improving standards of living, high urbanization rates and requirements for sanitation are the major growth drivers for Asia Pacific region, particularly in commercial and residential sectors.

Companies are investing in R&D for technological advancements, cost minimization, and production maximization. Technologies deployed for the production are thin-slab casting, electric furnace and vacuum degassing. Residential segment is expected to grow at a CAGR of 4.1%, from 2016 to 2025, owing to rapid urbanization and positive outlook on economic development. It minimizes the loads on foundations and also reduces sub-structure costs in residential buildings.

To request a sample copy or view summary of this report, click the link below: www.grandviewresearch.com/industry-analysis/structural-steel-market

Further key findings from the report suggest:

• Structural steel market volume was estimated at nearly 125 million tons in 2015, and is projected to grow at a CAGR of over 4.0% from 2016 to 2025
• North Asia emerged as the leading regional market and accounted for over 60% of the overall volume in 2015. North Asia is expected to grow significantly over the forecast period owing to increasing construction spending in countries such as China, Japan and Hong Kong
• Demand in construction industry is further driven by adoption of advancements in structural design methods, evolving building practices, and strong raw material availability
• Industrial applications are likely to generate high demand as well over the forecast period owing to governments focus towards construction development such as Smart Cities project in India
• India is one of the fastest emerging economies in steel production and is characterized by substantial number of economic reforms and implementation of merger & acquisition deals by companies.
• Major key operating companies include Baogang Group, Bohai Group Co., Ltd., Anshan Iron & Group Corporation, Anyang Iron & Group Corporation, Arcelor Mittal S.A., Benxi Beiying Group Co. Ltd., Evraz Group, Hebei Group, POSCO, Tata Limited, Steel Authority of India Limited, Gerdau S.A. and Nippon Steel & Sumitomo Metal Corporation (NSSMC)

Access More Reports Of The Same Category: www.grandviewresearch.com/industry/hvac-and-construction-technologies

Grand View Research has segmented the structural steel market on the basis application and region:

Structural Steel Application Outlook (Volume, Kilo Tons; Revenue, USD Million; 2014 - 2025)

• Non-residential
  • Industrial
  • Commercial
  • Offices
  • Institutional
• Residential

Structural Steel Regional Outlook (Volume, Kilo Tons; Revenue, USD Million; 2014 - 2025)

• North America
  • US.
  • Canada
  • Mexico
• Western Europe
  • Germany
  • UK
  • France
  • Spain
• Eastern Europe
  • Russia
  • Turkey
  • Poland
  • Rest of Eastern Europe
• North Asia
  • China
  • Taiwan
  • Japan
• Southeast Asia
  • Thailand
  • Malaysia
  • Singapore
  • Indonesia
  • Vietnam
  • Philippines
• South Asia
  • India
• Oceania
  • Australia
  • New Zealand
• Central & South America
  • Brazil
• Middle East & Africa
  • Saudi Arabia
  • UAE

Browse Press Release of this Report: www.grandviewresearch.com/press-release/global-structural-steel-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Water Treatment Systems Market Size Worth $44.01 Billion By 2025 | Key Industry participants 3M & Pentair PLC

San Francisco, 20 Dec 2018 - “Water Treatment Systems Market Size, Share & Trends Analysis Report By Technology (RO, Distillation, Disinfection, Filtration), By Application, By Installation (POU, POE), And Segment Forecasts, 2018 – 2025” - According to a report published by Grand View Research, Inc.; the global water treatment systems market is projected to reach around USD 44.01 billion by 2025. Rising levels of water pollution and government initiatives to reduce water contamination will drive the market. Rising consumer health awareness and demand for potable water are also expected to fuel the demand during the forecast period (2018 to 2025).

High awareness regarding the importance of clean water coupled with rising investments in efficient water purification and treatment facilities are anticipated to drive the market in near future. Additionally, easy availability of water treatment units and reduced manufacturing costs can positively impact market expansion. Growing level of pollution in rivers and lakes due to industrialization is also expected to boost the demand. Water treatment is essential to avoid prevalence of cholera, giardiasis, and other waterborne diseases. This factor is projected to propel the demand for these systems in the forthcoming years.

Access More Reports Of The Same Category: www.grandviewresearch.com/industry-analysis/water-treatment-systems-market

The worldwide water treatment systems market can be segmented on the basis of installation, technology, application, and region. Based on installation, the market can be classified into Point of Use (PoU) and Point of Entry (PoE). The PoU segment is anticipated to exhibit a volume-based CAGR of 16.7% during the forecast period attributed to convenient installation and affordable prices. High adoption of faucet mounted filter in emerging countries such as South Africa and India is anticipated to bode well for market growth. The POE segment was estimated to be worth 8.3 million units in 2016. High demand from North America and Europe owing to high aesthetic value of these installations is projected to drive the demand.

As per technology, the market can be categorized into filtration, disinfection, and reverse osmosis systems. In 2016, distillation systems was valued at USD 3.98 billion and is anticipated to display strong growth during the forecast period. The disinfection methods segment was estimated to be worth USD 3.60 billion in 2016. These methods utilize ultraviolet light, ozone, chloramines, chlorination, and chlorine dioxide. The filtration method segment held around 17.7% of overall market share owing to lower manufacturing costs.

Based on application, the market for water treatment systems can be bifurcated into residential and non-residential The non-residential segment is projected to rise at the fastest CAGR of 7.6% during the forecast period. The segment comprises commercial establishments, educational institutions, industrial units, and healthcare and recreational facilities. . The residential segment is likely to expand at a CAGR of 5.8% during the forecast period in terms of revenue. Growth in residential construction across the world is anticipated to propel this expansion.

Geographically, the market can be divided into North America, Europe, Asia Pacific, Central and South America, and Middle East and Africa. Asia Pacific is anticipated to dominate over the projected period owing to economic growth of China driven by massive rise in investments in technology and research. Significant changes in water supply and hygiene scenario owing to challenges such as water pollution, contamination, and scarcity are anticipated to further boost the demand. In 2016, India was one the leading markets for water treatment systems owing to large-scale water contamination and population explosion. The India market is expected to reach USD 3.64 billion over the forecast period.

In terms of revenue, Europe was reported as second largest market and occupied more than 26.0% in 2016. This growth can be credited to high requirement for efficient systems in residential as well as non-residential applications. In 2016, the U.K. estimated for 32.3 million units in terms of volume. The U.S. market is poised to rise at a CAGR of 3.3% during the forecast period in terms of revenue. This can be ascribed to supportive regulatory policies. In addition, economic benefits provided by vendors and distributors are anticipated to improve the business by 2015.

Key companies operating in the water treatment systems market include Watts Water Technologies Inc.; Honeywell Corporation; Aquasana, Inc.; Koninklijke Philips N.V.; and Dow Chemical Company.

Access More Reports Of The Same Category: www.grandviewresearch.com/industry/water-and-industrial-sludge-treatment

Grand View Research has segmented the global water treatment systems market on the basis of installation, technology, application, and region:

Water Treatment Systems InstallationOutlook (Volume, Million Units; Revenue, USD Billion, 2014 - 2025)

• Point of Use
• Point of Entry 

Water Treatment Systems Technology Outlook (Volume, Million Units; Revenue, USD Billion, 2014 - 2025)

• Reverse Osmosis systems
• Distillation systems
• Disinfection methods
• Filtration methods

Water Treatment Systems ApplicationOutlook (Volume, Million Units; Revenue, USD Billion, 2014 - 2025)

• Residential
• Non-residential

Water Treatment Systems Regional Outlook (Volume, Million Units; Revenue, USD Billion, 2014 - 2025)

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • Russia
  • U.K.
  • Spain
  • Italy
• Asia Pacific
  • China
  • Japan
  • South Korea
  • Australia
  • India
• Central & South America
  • Brazil
• Middle East and Africa
  • UAE
  • Saudi Arabia

Browse Press Release of this Report: www.grandviewresearch.com/press-release/global-water-treatment-systems-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com